ALEXANDRIA, Va., July 23 -- United States Patent no. 12,367,951, issued on July 22, was assigned to AxiomBio Inc. (San Francisco).
"Optimizing molecule toxicity by replacing target fragments with bioisosteres" was invented by Brandon White (San Francisco), Alexander Bremner Upjohn Beatson (San Francisco), Katherine Lynn Titterton (San Francisco), Daniil Boiko (San Francisco), Angel Alexander Cabrera (San Francisco) and Alex Tim Bauerle (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for predicting toxicity of molecules. In one aspect, a method comprises: obtaining data identifying: (i) an input mo...